Preview
March 2019
In the next issue of Pharma Technology Focus, we find out why there is currently no supply of the pink Migraleve over-the-counter migraine tablets – which contain buclizine to relieve nausea on the onset of migraine – in the UK, explore the potential of modifying non-toxic nano-material from corn into active ingredients for targeted drug delivery, imaging or diagnostics, and examine how machine learning is helping to accelerate research into personalised medicines and rare diseases.
Also, we take a look at Scotland’s pharmaceutical industry and what needs to happen for the country to maintain its status as an industry leader, and examine how thermostabilised viral vaccines can help ensure the optimal potency of vaccines in developing countries.
Plus, we explore what biotech’s biggest ever IPO tells us about drug manufacturing and check on the outlook for CRISPR gene editing technology at this important juncture.
EDITORIAL
Editor | Eloise McLennan
Group Editor | Susanne Hauner
Commissioning Editor | Daniel Garrun
Writers | Allie Nawrat, Charlotte Edwards, Chris Lo, Ross Davies, Christian Hebenstreit
Magazine Designer | Marzia Del Gaone
Graphic Designers | Paulius Zutautas, Kate Cuntapay, Anett Arc, Sara Basto, Ashley McPherson, Tyrrell Lowe, Noemi Balint
Lead Designer | John Hammond
Digital Publishing Director | Duncan West
Advertising
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
Marketing
Media Partnership Enquiries | Susanne Hauner
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Pharma Technology Focus is a product of Net Resources International. Copyright 2018 Net Resources International, a trading division of Kable Intelligence Limited. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.